ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Employment"

  • Abstract Number: 2417 • 2012 ACR/ARHP Annual Meeting

    Transitioning to Adulthood: Employment Experiences of Young Adults with Lupus and Juvenile Arthritis

    Arif Jetha1, E. M. Badley2, Dorcas Beaton3, Paul R. Fortin4, Natalie J. Shiff5, Alan M. Rosenberg6, Lori B. Tucker7, Dianne P. Mosher8 and M. A. Gignac9, 1Health Care and Outcomes Research, Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 2Division of Health Care and Outcomes Research,Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 3Research, Mobility Program Clinical Research Unit, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada, 4Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada, 5Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 6Department of Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 7Pediatric Rheum/Rm K4-120, BC Childrens Hospital, Vancouver, BC, Canada, 8Med, University of Calgary, Calgary, AB, Canada, 9Divison of Health Care & Outcomes Research, Health Care and Outcomes Research, Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto; Institute for Work & Health, Toronto, ON, Canada

    Background/Purpose: A considerable body of evidence highlights the negative impact of rheumatic disease on employment. However, most research examines middle- and older-aged adults. We lack…
  • Abstract Number: 2231 • 2012 ACR/ARHP Annual Meeting

    Treatment of Psoriatic Arthritis with Tumour Necrosis Factor á Antagonists Successfully Maintains Work Capacity: 2 Year Results of a Prospective Cohort Study

    Leonard C. Harty1, Alex Franciosi2, Naomi Pettysan2, Paul Rushe2 and Oliver M. FitzGerald1, 1Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 2Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland

    Background/Purpose: Treatment resistant psoriatic arthritis (PsA) may render a patient unwell, disabled and incapable of work with previous reports suggesting that unemployment levels among PsA…
  • Abstract Number: 1381 • 2012 ACR/ARHP Annual Meeting

    Non-Radiographic  Spondyloarthritis Has Greater Work Instability Than Other Spondyloarthritis Subtypes in a National Database

    Sherry Rohekar1, Robert D. Inman2, Renise Ayearst3, Proton Rahman4, Walter P. Maksymowych5 and Dafna D. Gladman6, 1Rheumatology, St. Joseph's Hospital, London, ON, Canada, 2Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 5Department of Medicine, University of Alberta, Edmonton, AB, Canada, 6Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, University Health Network, Toronto, ON, Canada

    Background/Purpose: Clinical subsets of spondyloarthritis (SpA), such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can be associated with significant impact on work performance and…
  • Abstract Number: 493 • 2012 ACR/ARHP Annual Meeting

    Effect of Infliximab On Employment Status in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis

    W. Bensen1, J. Carter Thorne2, Saeed A. Shaikh3, Maqbool K. Sheriff4, Susan M. Otawa5, Allen J. Lehman5 and Hayssam Khalil6, 1St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Medicine, McMaster University, St Catharines, ON, Canada, 4Nanaimo Regional General Hospital, Nanaimo, BC, Canada, 5Medical Affairs, Janssen Inc., Toronto, ON, Canada, 6Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada

    Background/Purpose: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with significant functional impairment and work disability. In the absence of treatment, approximately 80% of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology